Edap tms sa- adr EDAP.US 總覽分析

美股醫療保健
(EDAP 無簡報檔)

EDAP 投資分析

看多重點：

  • 價值≥4
  • 股利≥2

分析結論

價值面評分中等，已經有部位可以持續持有，若想建立新部位可以等待價值評分轉變為4分以上、股利提升為2分以上

EDAP 近期報酬表現

-3.15%

Edap tms sa- adr

4.57%

同產業平均

3.26%

S&P500

與 EDAP 同產業的標的表現

  • AHCO Adapthealth corp
    價值 4 分趨勢 2 分波段 2 分籌碼 4 分股利 1 分
    查看更多

EDAP 公司資訊

Edap Tms SA is a France-based company that develops, manufactures, promotes and distributes minimally invasive medical devices for urology based upon ultrasound technology. The Company's activity is organized in two divisions: HIFU (High Intensity Focused Ultrasound) and ESWL (Extracorporeal ShockWave Lithotripsy) that invests in research and development, partnering with INSERM French public laboratory and international medical research institutions. It specialises in HIFU technology, a non-invasive treatment of prostate conditions with a range of Robotic HIFU devices, Ablatherm Fusion and Focal One, ESWL and Stone Laser that offers a range of minimally invasive solutions covering the full scope of urinary tract stone indications. It also operates worldwide via a network of corporate offices, subsidiaries and distribution partners

EDAP 股價